{"id":5773,"date":"2021-12-08T14:13:27","date_gmt":"2021-12-08T20:13:27","guid":{"rendered":"http:\/\/pharmgate.com\/usa\/?p=5773"},"modified":"2022-11-09T20:31:24","modified_gmt":"2022-11-10T02:31:24","slug":"virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health","status":"publish","type":"post","link":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/","title":{"rendered":"Virbac announces the approval of TULISSIN\u00ae<\/sup> (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health"},"content":{"rendered":"

Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of TULISSIN\u00ae<\/sup> (Tulathromycin injectable) Injectable Solution for use in cattle and swine. The product will be available in two concentrations: 100 mg\/ml and 25 mg\/ml to properly cover the two segments. TULISSIN 100 Injectable Solution will be available in 500, 250, 100 and 50 ml bottles and TULISSIN 25 Injectable Solution in 250 and 100 ml bottles.<\/p>\n

Virbac will market the cattle products with its own direct sales force; whereas for swine, Virbac announces that it has entered into an agreement with Pharmgate. Under this arrangement, Pharmgate, with a very robust sales and technical services division, will represent Virbac to swine veterinarians and producers across the U.S.<\/p>\n

Virbac has a very strong presence in the large animal health segment in several regions, including Asia, Pacific, Europe and Latin America. This will be Virbac\u2019s first foray into this segment for the U.S. market.<\/p>\n

\u201cWe are excited to collaborate with a reputable animal health organization, such as Virbac, as they launch a range of products into the U.S. large animal market,\u201d says Ed Seed, head of Global Sales & Marketing for Pharmgate. \u201cAdding this initial product, TULISSIN, to our portfolio over the coming year will expand our offering in fulfilling our customers\u2019 complete therapeutic product needs.\u201d<\/p>\n

\u201cWe see the market authorization of TULISSIN as a major accomplishment and are excited about our introduction into the food producing animal market for the U.S. I am convinced that Pharmgate, with its broad portfolio of products and strong field team, key relationships and expertise, is a perfect fit for Virbac to successfully enter the swine segment,\u201d says Francois Fournier, president & CEO, Virbac North America.<\/p>\n\n\n\n
\"\"<\/td>\n\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

For full prescription and safety information about:
\nTULISSIN 25 Injectable Solution CLICK HERE<\/strong><\/a>
\nTULISSIN 100 Injectable Solution CLICK HERE<\/strong><\/a><\/p>\n

At Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range of products and services enables us to diagnose, prevent and treat the majority of pathologies. Every day, we are committed to improving animals\u2019 quality of life and to shaping together the future of animal health.<\/p>\n

Pharmgate Animal Health LLC is the joint venture between Pharmgate LLC, the majority-owned U.S. subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, and other animal health compounds and ECO Animal Health, London U.K., a leader in the development, registration and marketing of pharmaceutical products for global animal health markets including Aivlosin\u00ae<\/sup>, as well as a range of branded generic animal health therapeutic products.<\/p>\n","protected":false},"excerpt":{"rendered":"

Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of TULISSIN\u00ae (Tulathromycin<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[127],"product":[],"active_ingredient":[],"species_vfd":[],"indication":[],"blue_bird_label":[],"watersolutions":[],"post-category":[185],"class_list":["post-5773","post","type-post","status-publish","format-standard","hentry","category-news","post-category-news"],"acf":[],"yoast_head":"\nVirbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA\" \/>\n<meta property=\"og:description\" content=\"Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of TULISSIN\u00ae (Tulathromycin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/\" \/>\n<meta property=\"og:site_name\" content=\"USA\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-08T20:13:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-10T02:31:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png\" \/>\n<meta name=\"author\" content=\"Padilla\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Padilla\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/\",\"url\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/\",\"name\":\"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA\",\"isPartOf\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png\",\"datePublished\":\"2021-12-08T20:13:27+00:00\",\"dateModified\":\"2022-11-10T02:31:24+00:00\",\"author\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/#\/schema\/person\/39da7e50fdd1c7b8e3c1c8c66036efae\"},\"breadcrumb\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage\",\"url\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png\",\"contentUrl\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png\",\"width\":210,\"height\":210,\"caption\":\"TULISSIN 100ml Injectable Solution\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pharmgate.com\/usa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pharmgate.com\/usa\/#website\",\"url\":\"https:\/\/pharmgate.com\/usa\/\",\"name\":\"USA\",\"description\":\"USA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pharmgate.com\/usa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pharmgate.com\/usa\/#\/schema\/person\/39da7e50fdd1c7b8e3c1c8c66036efae\",\"name\":\"Padilla\",\"url\":\"https:\/\/pharmgate.com\/usa\/news\/author\/padilla\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/","og_locale":"en_US","og_type":"article","og_title":"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA","og_description":"Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of TULISSIN\u00ae (Tulathromycin","og_url":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/","og_site_name":"USA","article_published_time":"2021-12-08T20:13:27+00:00","article_modified_time":"2022-11-10T02:31:24+00:00","og_image":[{"url":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png"}],"author":"Padilla","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Padilla","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/","url":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/","name":"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health - USA","isPartOf":{"@id":"https:\/\/pharmgate.com\/usa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage"},"image":{"@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png","datePublished":"2021-12-08T20:13:27+00:00","dateModified":"2022-11-10T02:31:24+00:00","author":{"@id":"https:\/\/pharmgate.com\/usa\/#\/schema\/person\/39da7e50fdd1c7b8e3c1c8c66036efae"},"breadcrumb":{"@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#primaryimage","url":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png","contentUrl":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-25_100ml_Packshot_WEB_210X210_face.png","width":210,"height":210,"caption":"TULISSIN 100ml Injectable Solution"},{"@type":"BreadcrumbList","@id":"https:\/\/pharmgate.com\/usa\/news\/virbac-announces-the-approval-of-tulissin-tulathromycin-injectable-injectable-solution-in-the-u-s-and-a-collaboration-with-pharmgate-animal-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmgate.com\/usa\/"},{"@type":"ListItem","position":2,"name":"Virbac announces the approval of TULISSIN\u00ae (Tulathromycin injectable) Injectable Solution in the U.S. and a collaboration with Pharmgate Animal Health"}]},{"@type":"WebSite","@id":"https:\/\/pharmgate.com\/usa\/#website","url":"https:\/\/pharmgate.com\/usa\/","name":"USA","description":"USA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmgate.com\/usa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pharmgate.com\/usa\/#\/schema\/person\/39da7e50fdd1c7b8e3c1c8c66036efae","name":"Padilla","url":"https:\/\/pharmgate.com\/usa\/news\/author\/padilla\/"}]}},"_links":{"self":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/posts\/5773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/comments?post=5773"}],"version-history":[{"count":37,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/posts\/5773\/revisions"}],"predecessor-version":[{"id":7591,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/posts\/5773\/revisions\/7591"}],"wp:attachment":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/media?parent=5773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/categories?post=5773"},{"taxonomy":"product","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/product?post=5773"},{"taxonomy":"active_ingredient","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/active_ingredient?post=5773"},{"taxonomy":"species_vfd","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/species_vfd?post=5773"},{"taxonomy":"indication","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/indication?post=5773"},{"taxonomy":"blue_bird_label","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/blue_bird_label?post=5773"},{"taxonomy":"watersolutions","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/watersolutions?post=5773"},{"taxonomy":"post-category","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/post-category?post=5773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}